应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AMGN 安进
休市中 11-13 16:00:00 EST
465.67
-1.39
-0.30%
盘后
465.00
-0.67
-0.14%
19:57 EST
最高
468.00
最低
462.22
成交量
212.23万
今开
467.53
昨收
467.06
日振幅
1.24%
总市值
2,508亿
流通市值
2,508亿
总股本
5.38亿
成交额
9.88亿
换手率
0.39%
流通股本
5.38亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
安进(AMGN)创新药达唑达利贝治疗干燥综合征3期临床试验取得积极结果
金吾财讯 · 11-11
安进(AMGN)创新药达唑达利贝治疗干燥综合征3期临床试验取得积极结果
安进Dazodalibep在3期OASIZ-301试验中达到主要终点。
智通财经 · 11-11
安进Dazodalibep在3期OASIZ-301试验中达到主要终点。
异动解读|安进盘前下跌3.02%,多家投行上调目标价后股价回落
行情直击 · 11-06
异动解读|安进盘前下跌3.02%,多家投行上调目标价后股价回落
异动解读|安进盘中下跌3.03%,多家投行上调目标价后股价回落
行情直击 · 11-06
异动解读|安进盘中下跌3.03%,多家投行上调目标价后股价回落
小摩上调安进目标价至425美元
格隆汇 · 11-05
小摩上调安进目标价至425美元
异动解读|安进盘中上涨3.56%,花旗上调目标价至465美元
行情直击 · 11-04
异动解读|安进盘中上涨3.56%,花旗上调目标价至465美元
异动解读|安进盘前上涨3.57%,花旗上调目标价至465美元
行情直击 · 11-04
异动解读|安进盘前上涨3.57%,花旗上调目标价至465美元
花旗:安进(AMGN.US)多元化业务增长抵消地舒单抗产品营收下滑 研发管线执行情况将决定未来前景
智通财经 · 11-04
花旗:安进(AMGN.US)多元化业务增长抵消地舒单抗产品营收下滑 研发管线执行情况将决定未来前景
美股夜盘|绩优股表现亮眼!AMD涨超4%、超微电脑涨超7%、多邻国涨超13%
美股夜盘 · 11-04
美股夜盘|绩优股表现亮眼!AMD涨超4%、超微电脑涨超7%、多邻国涨超13%
安进Q3业绩超市场预期,但生物类似药竞争对关键产品影响显著
老虎资讯综合 · 11-04
安进Q3业绩超市场预期,但生物类似药竞争对关键产品影响显著
安进(AMGN.US)Q3营收、利润超预期 并上调全年指引
智通财经 · 11-04
安进(AMGN.US)Q3营收、利润超预期 并上调全年指引
安进第三季度调整后每股收益6.45美元,预估5.77美元。
智通财经 · 11-04
安进第三季度调整后每股收益6.45美元,预估5.77美元。
异动解读|安进盘中上涨3.07%,肺癌联合疗法进展叠加机构看多
行情直击 · 10-30
异动解读|安进盘中上涨3.07%,肺癌联合疗法进展叠加机构看多
异动解读|安进盘前上涨3.1%,肺癌联合疗法进展叠加机构看多
行情直击 · 10-30
异动解读|安进盘前上涨3.1%,肺癌联合疗法进展叠加机构看多
美股夜盘 | 芯片股集体重挫,英特尔暴跌逾22%,ARM跌超7%,闪迪、美光等存储股普跌
美股夜盘 · 10-30
美股夜盘 | 芯片股集体重挫,英特尔暴跌逾22%,ARM跌超7%,闪迪、美光等存储股普跌
异动解读|安进盘中上涨3.48%,肺癌联合疗法进展叠加机构上调目标价
行情直击 · 10-29
异动解读|安进盘中上涨3.48%,肺癌联合疗法进展叠加机构上调目标价
异动解读|安进盘前上涨3.17%,肺癌联合疗法进展叠加机构上调目标价
行情直击 · 10-29
异动解读|安进盘前上涨3.17%,肺癌联合疗法进展叠加机构上调目标价
异动解读|安进夜盘上涨3.58%,联合疗法积极数据叠加机构看多
行情直击 · 10-29
异动解读|安进夜盘上涨3.58%,联合疗法积极数据叠加机构看多
财报前瞻 | 安进本季度营收预计增12.31%,机构观点看多
财报Agent · 10-27
财报前瞻 | 安进本季度营收预计增12.31%,机构观点看多
美股异动丨安进盘前涨超1% 联合疗法在小细胞肺癌治疗上取得积极研究结果
格隆汇 · 10-26
美股异动丨安进盘前涨超1% 联合疗法在小细胞肺癌治疗上取得积极研究结果
公司概况
公司名称:
安进
所属市场:
NASDAQ
上市日期:
--
主营业务:
安进公司于1980年在加利福尼亚成立,并于1987年成为特拉华州的一家公司。该公司发现、开发、制造和交付创新药物,以对抗世界上一些最棘手的疾病。该公司专注于高度未满足的医疗需求领域,并利用其专业知识努力寻求能够显著改善人们生活的解决方案,同时还能减轻疾病带来的社会和经济负担。该公司在40多年前帮助启动了生物技术产业,并已成长为世界领先的独立生物技术公司之一。
发行价格:
--
{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"安进","latestPrice":465.67,"timestamp":1794603600000,"preClose":467.06,"halted":0,"volume":2122345,"hourTrading":{"tag":"盘后","latestPrice":465,"preClose":465.67,"latestTime":"19:57 EST","volume":958389,"amount":446292177.1297,"timestamp":1794617821486,"change":-0.67,"changeRate":-0.001439,"amplitude":0.002427},"delay":0,"changeRate":-0.0029760630325867906,"floatShares":538480671,"shares":538480671,"eps":17.260212,"marketStatus":"休市中","change":-1.39,"latestTime":"11-13 16:00:00 EST","open":467.53,"high":468,"low":462.22,"amount":988244268.8755,"amplitude":0.012375,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":17.260212,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":467.06,"dividendRate":0.021364,"preHourTrading":{"tag":"盘前","latestPrice":467.58,"preClose":467.06,"latestTime":"09:29 EST","volume":1736,"amount":812809.088,"timestamp":1794580199999,"change":0.52,"changeRate":0.001113,"amplitude":0.012672},"postHourTrading":{"tag":"盘后","latestPrice":465,"preClose":465.67,"latestTime":"19:57 EST","volume":958389,"amount":446292177.1297,"timestamp":1794617821486,"change":-0.67,"changeRate":-0.001439,"amplitude":0.002427},"volumeRatio":0.8943656203008581,"impliedVol":0.3051,"impliedVolPercentile":0.5378},"requestUrl":"/m/hq/s/AMGN/wiki","defaultTab":"wiki","newsList":[{"id":"2682307554","title":"安进(AMGN)创新药达唑达利贝治疗干燥综合征3期临床试验取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2682307554","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682307554?lang=zh_cn&edition=full","pubTime":"2026-11-11 21:30","pubTimestamp":1794403851,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物制药巨头安进 宣布,其创新药达唑达利贝在治疗干燥综合征的全球3期OASIZ-301临床试验中取得关键突破,两项主要给药方案均成功达到主要终点。作为目前全球首个在同类研究中同时改善全身疾病活动度与患者自述症状的3期临床试验,该成果后续有望填补该领域尚无FDA批准疗法的空白。分析人士指出,鉴于干燥综合征目前尚无有效获批治疗药物,达唑达利贝有望成为同类首创疗法,进一步丰富安进在免疫与炎症领域的创新产品矩阵。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/ODI2NGE1NjlmODgxZDI1NzFmMmQ4ODQzNDA1OTI5NjU2Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ODI2NGE1NjlmODgxZDI1NzFmMmQ4ODQzNDA1OTI5NjU2Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"308247","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2112291526.USD","PJP","LU1236620750.USD","BK1161","IE0002141913.USD","LU0889565916.HKD","LU0109394709.USD","159992","BK4534","BIB","BK4585","06978","MEDX","BK4581","BK4139","IBBJ","LU1236620834.HKD","IBB","LU0868494617.USD","BK1574","SG9999001440.SGD","LU1023059063.AUD","LU0058720904.USD","TBXU","PSYK","LU2242652126.USD","AMGN","LU0122379950.USD","BBH","LNGR","PBE","IE00BFTCPJ56.SGD","BK4588","BK4566","IE00BJT1NW94.SGD","LU2089984988.USD","MDTX","BMED","BK4599","IE0009355771.USD","LU2242646821.SGD","IBBQ","IE00BJJMRZ35.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD","BK4533","IE00B2B36J28.USD","LU2468319806.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682304263","title":"安进Dazodalibep在3期OASIZ-301试验中达到主要终点。","url":"https://stock-news.laohu8.com/highlight/detail?id=2682304263","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682304263?lang=zh_cn&edition=full","pubTime":"2026-11-11 21:00","pubTimestamp":1794402055,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AMGN","BK4599","IE0002141913.USD","LU2468319806.SGD","LU0289739699.SGD","BK4533","LU2242652126.USD","IE0009355771.USD","LU0058720904.USD","LU2242646821.SGD","BK4139","LU1571399168.USD","LU2112291526.USD","BK4585","LU2089984988.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU1236620750.USD","LU1236620834.HKD","IBBQ","SG9999001440.SGD","LU0868494617.USD","BK4581","TBXU","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU1983299246.USD","PJP","LU1023059063.AUD","LU0109394709.USD","LU0889565916.HKD","BK4566","IE00B2B36J28.USD","LU1061106388.HKD","BK4534","PBE","BK4588","BIB","BBH","IBB","LU0122379950.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100729713","title":"异动解读|安进盘前下跌3.02%,多家投行上调目标价后股价回落","url":"https://stock-news.laohu8.com/highlight/detail?id=1100729713","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100729713?lang=zh_cn&edition=full","pubTime":"2026-11-06 22:28","pubTimestamp":1793975322,"startTime":"0","endTime":"0","summary":"11月6日,安进盘前下跌3.02%,报446.88美元/股,成交额261.36万美元。消息面上,公司近两日虽获多家机构上调目标价,但股价在前期财报利好与估值上修后出现回落。此前公司披露第三季度调整后每股收益6.45美元、营收103.65亿美元,均高于预期,并上调全年营收指引至389亿至397亿美元、调整后每股收益指引至22.90至23.70美元。机构方面,瑞银将目标价上调至530美元,古根海姆上调至435美元,小摩上调至425美元。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"安进财报超预期后回落,投行却集体上调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132137274","title":"异动解读|安进盘中下跌3.03%,多家投行上调目标价后股价回落","url":"https://stock-news.laohu8.com/highlight/detail?id=1132137274","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132137274?lang=zh_cn&edition=full","pubTime":"2026-11-06 04:12","pubTimestamp":1793909561,"startTime":"0","endTime":"0","summary":"11月6日,安进盘中下跌3.03%,报463.995美元/股,成交额11.7亿美元。消息面上,公司近两日虽获多家机构上调目标价,但股价在前期财报利好与估值上修后出现回落。此外,公司此前披露第三季度调整后每股收益6.45美元、营收103.65亿美元,均高于预期,并上调全年营收指引至389亿至397亿美元、调整后每股收益指引至22.90至23.70美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"安进股价回落,投行上调目标价后转弱","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681041219","title":"小摩上调安进目标价至425美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681041219","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681041219?lang=zh_cn&edition=full","pubTime":"2026-11-05 16:40","pubTimestamp":1793868034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1119994496.HKD","JPO","IBB","TFNS","LU0859254822.USD","TRUF","PJP","LU0345770993.USD","LU2430703095.HKD","IYF","BK4599","IE000WAW04H5.SGD","IBBQ","LU2242646821.SGD","IYG","LU2237443895.HKD","IE00BKDWB100.SGD","AMGN","LU2746668974.SGD","UUP","UYG","VFH","LU0265550946.USD","LU0211326755.USD","BBH","LU2417539215.USD","IE00BLSP4452.SGD","LU0943347566.SGD","LU1974910355.USD","LU0971096721.USD","LU0345770308.USD","LU0006306889.USD","LU0964807845.USD","TBXU","XLF","LU2211815571.USD","BK4566","FNCL","PBE","IXG","BIB","LU0320765489.SGD","FTXO","LU0787776722.HKD","LU2054465674.USD","LU1363072403.SGD","UDN","LU0109394709.USD","KBWB","JPMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189220412","title":"异动解读|安进盘中上涨3.56%,花旗上调目标价至465美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189220412","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189220412?lang=zh_cn&edition=full","pubTime":"2026-11-04 22:30","pubTimestamp":1793802625,"startTime":"0","endTime":"0","summary":"11月4日,安进盘中上涨3.56%,报479.8美元/股,成交额7228.93万美元。此次异动的直接催化是花旗将安进目标价由405美元上调至465美元,带动市场情绪回暖。公司此前披露第三季度营收103.65亿美元、调整后每股收益6.45美元,均高于市场预期,并将全年营收指引上调至389亿至397亿美元、调整后每股收益指引上调至22.90至23.70美元。尽管Prolia与XGEVA销售额分别同比下滑45%和47%,但多元化业务增长与指引上修对股价形成支撑。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安进获花旗上调目标价,股价应声上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165547263","title":"异动解读|安进盘前上涨3.57%,花旗上调目标价至465美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165547263","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165547263?lang=zh_cn&edition=full","pubTime":"2026-11-04 20:48","pubTimestamp":1793796522,"startTime":"0","endTime":"0","summary":"11月4日,安进盘前上涨3.57%,报474.0美元/股,成交额963.55万美元。此次异动的直接催化来自最新投行调整:花旗将安进目标价从405美元上调至465美元。此前公司公布第三季度营收103.65亿美元、调整后每股收益6.45美元,均高于市场预期,并上调全年营收指引至389亿至397亿美元、调整后每股收益指引至22.90至23.70美元。市场同时关注到Prolia与XGEVA受生物类似药冲击,相关销售额分别同比下滑45%和47%,但多元化业务增长与指引上修仍对股价形成支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安进盘前上涨,花旗上调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680770729","title":"花旗:安进(AMGN.US)多元化业务增长抵消地舒单抗产品营收下滑 研发管线执行情况将决定未来前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2680770729","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680770729?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:16","pubTimestamp":1793758607,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,11月3日(周二)美股盘后,安进公布了2026年第三季度业绩。花旗认为,安进上调了全年业绩指引进一步增强了市场对其商业化执行能力的信心,但其远期估值倍数越来越取决于研发管线能否兑现预期。花旗维持对安进“中性”评级,目标价405美元。花旗表示,1)产品组合的多元化仍在持续消化地舒单抗产品营收下滑的影响,其中Repatha和罕见病业务是主要增长动力。据悉,安进在第三季度报告三项III期阳性结果。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LFSC","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192092021","title":"美股夜盘|绩优股表现亮眼!AMD涨超4%、超微电脑涨超7%、多邻国涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192092021","media":"美股夜盘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192092021?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:06","pubTimestamp":1793754383,"startTime":"0","endTime":"0","summary":"Arista Networks, Inc. 涨8.00%,Q3业绩与Q4指引均超预期。Lumentum跌2.36%,美银称迈威尔科技拟收购或促使思科、Ciena分散供应。Palantir跌2.71%,期权现熊市看涨价差,偏空。其中,美国超微公司受季报与指引超预期提振。大科技股票下跌,SpaceX跌2.75%,特斯拉跌2.66%,亚马逊跌1.51%,微软跌1.37%,谷歌A跌1.15%,英伟达跌1.04%,苹果跌1.03%。其中,苹果受双买Put及熊市看跌价差等看跌布局影响。其中,西部数据受大额卖出Put收租资金影响。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434583.USD","LU1791807156.HKD","LU2360106780.USD","LU0133085943.USD","LU2244417387.USD","LU0109391861.USD","LU1880398554.USD","LU0353189680.USD","BK4570","LU0889566641.SGD","IE00B4R5TH58.HKD","NVTC","LU2361044949.HKD","SMHX","LU0823421416.USD","SMCI","XME","AMUU","BK4585","DUOG","LU0820561909.HKD","IE00BKVL7J92.USD","BK4532","LU0979878070.USD","BK4020","IE00BQXX3C00.GBP","LU1861220033.SGD","LU0823421333.USD","IE00BMPRXN33.USD","LU0289739699.SGD","LU1551013342.USD","LU0353189763.USD","HL","LU1935043536.SGD","LU1316542783.SGD","BK4581","IE0004091025.USD","LU1145028129.USD","LU2360107168.USD","LU2417539215.USD","IE0004445239.USD","NVTX","LU0210536198.USD","SMH","LU2089984988.USD","AMD","LU1232071149.USD","ARTY","LU2756315664.SGD","LU2265009873.SGD","GAMR","IE00BJJMRZ35.SGD","LU1861559042.SGD","LU2213496289.HKD","AMDC","LU0820562030.AUD","LU0820561818.USD","LU0109392836.USD","LU1303367103.USD","LU1935043023.USD","LU1061106388.HKD","SMCC","LU2242652126.USD","LU1917777945.USD","LU0320765992.SGD","BBH","LU2543165471.USD","BK4612","DAMD","LU1988902786.USD","LU2999663052.SGD","TTEQ","BK4539","LU1803068979.SGD","XYZ","LU2023250330.USD","LU2954938101.SGD","LU0077335932.USD","AIS","IE00B5949003.HKD","LU1861220207.SGD","BK4605","IE00BN0W2W23.USD","SKYY","IE00BMPRXR70.SGD","BK4599","LU1861217088.USD","BIB","LU1668664300.SGD","ANEL","LU2931357623.SGD","IE0008368304.USD","LU0792757196.USD","LU0786609619.USD","BK7504","XTL","BK4170","SG9999001424.SGD","SGXZ51526630.SGD","SLVP","LU1974910355.USD","SOXX","LU2236285917.USD","LU2461242641.AUD","LU2456880835.USD","LU2250418816.HKD","LU1951198990.SGD","BK4573","IE0002270589.USD","LU2242646821.SGD","SLJY","LU2247934214.USD","BK4515","LU0256863811.USD","ILDR","AMDL","LU1571399168.USD","XYZY","LU1989772840.SGD","BK4512","IE00BQXX3F31.USD","LU0143551892.USD","LU2355687059.USD","LU1989764664.SGD","LU1935042215.USD","BK4534","LU0964807845.USD","SG9999001440.SGD","IE00B2B36J28.USD","LU2023250504.SGD","AMDS","SWKS","IE00BQXX3D17.EUR","IE00B19Z3B42.SGD","NVTS","SILJ","BK4543","IE00BMPRXQ63.HKD","LU0053671581.USD","LU1242518931.SGD","LU1923623000.USD","SGXZ81514606.USD","LU0390134368.USD","LU0274383776.USD","IBBQ","AMDU","LU1023059063.AUD","LU2211814178.USD","WUGI","LU2360107671.USD","BK4141","LU0006306889.USD","LU2098885051.SGD","LU1935042488.USD","LU2896262040.SGD","LU2242649171.HKD","TRFK","LU2054465674.USD","TBXU","LU1057294990.SGD","LU0672654240.SGD","BAI","LU2211815571.USD","LU0320765059.SGD","SOXY","CHAT","IETC","AMGN","LU2286300806.USD","SAMD0main","LU2087625088.SGD","IE00B19Z8X17.USD","IE00BHPRN162.USD","LU1267930730.SGD","IE00BN0W2V16.EUR","BK4575","IE00B19Z9505.USD","LU0109394709.USD","AMD.AU","LU2108987350.USD","BK4598","LU1629891620.HKD","LU0198837287.USD","TEK","GFSG","SMCX","AMDG","LU2211817866.USD","LU2860962120.EUR","IE0004086264.USD","SGXZ99366536.SGD","QQQA","BK7158","LU1852331112.SGD","LU0889565833.HKD","LU2361044865.SGD","LU0823434740.USD","IE00B19Z8W00.USD","LU0345780281.USD","AMDY","LU1236620834.HKD","BK4614","WISE","LU0058720904.USD","LU1267930813.SGD","IE00BJT1NW94.SGD","BK4533","LU0417517546.SGD","AIQ","SMYY","XYZ.AU","CHPS","IE00BZ1G4Q59.USD","LU0174119429.USD","LU2403377893.USD","LU1923622614.USD","LEGR","LU2264538146.SGD","LU1983299246.USD","LU0082616367.USD","BK4566","SIL","AMDW","IE0001KFT4U8.USD","LU1861558580.USD","LU0943347566.SGD","LU1551013425.SGD","LU0719512351.SGD","LU1236620750.USD","LU1989764748.USD","LU0689472784.USD","IE0002141913.USD","LU0127658192.USD","IYZ","FTXL","IBB","BK4139","BK4227","LU1989772923.USD","FTK","BK4613","USXF","LU2290526834.HKD","XYZG","LU0106261372.USD","PJP","LU2089985449.USD","LU0889565916.HKD","LU0642271901.SGD","LU2106854487.HKD","HLXX","BK4109","SMCL","LU2433249047.HKD","AMDD","ANET","IE0009356076.USD","CNAV","LU0868494617.USD","DUOL","LU0056508442.USD","LU1861215975.USD","LU0345780521.USD","LU2458330169.SGD","LU2112291526.USD","BK4210","PSI","LU0081259029.USD","LU2468319806.SGD","LU0048584097.USD","LU1935043452.HKD","BK4554","LU2458330243.SGD","LU1242518857.USD","LU0187121727.USD","LU0256863902.USD","LU2756315318.SGD","SMCZ","IE0009355771.USD","IE00BN0W2T93.GBP","BK4204","LU0348723411.USD","LU2125909593.SGD","GFS","LU1064131342.USD","LU1935042991.SGD","LU2462591277.SGD","IE00B1BXHZ80.USD","FAI","LU2125909247.SGD","XNTK","LU0708995401.HKD","BK7095","PBE","LU1951200564.SGD","SMCY","LU1804176565.USD","BK4588","LU0251132253.USD","LU0106831901.USD","AMYY","LU0557290698.USD","LU1880398471.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","LU2361045086.USD","LU2462591350.SGD","LU0225283273.USD","LU0122379950.USD","BK4529"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1125809504","title":"安进Q3业绩超市场预期,但生物类似药竞争对关键产品影响显著","url":"https://stock-news.laohu8.com/highlight/detail?id=1125809504","media":"老虎资讯综合","labels":["EditorSelect"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125809504?lang=zh_cn&edition=full","pubTime":"2026-11-04 07:36","pubTimestamp":1793748992,"startTime":"0","endTime":"0","summary":"11月4日,安进盘后跌超1%,该公司公布的第三季度业绩超出华尔街预期,投资者权衡生物类似药竞争对关键产品的影响。尽管业绩强劲,但市场对Prolia和XGEVA等产品面临生物类似药竞争的担忧,掩盖了这一业绩。生物类似药的竞争对某些产品造成了显著影响。由于多种生物类似药在全球上市,Prolia的销售额同比暴跌45%至6.32亿美元,而XGEVA的销售额也下降了47%至2.88亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安进Q3业绩超市场预期,但生物类似药竞争对关键产品影响显著","news_tag":"EditorSelect","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680705893","title":"安进(AMGN.US)Q3营收、利润超预期 并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2680705893","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680705893?lang=zh_cn&edition=full","pubTime":"2026-11-04 06:19","pubTimestamp":1793744379,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,安进11月3日美股盘后发布2026年三季报:总营收103.65亿美元,同比增长8%,高于市场预估的约100.5亿美元;非GAAP每股收益6.45美元,同比增长14%,明显高于预估的5.77美元;GAAP每股收益7.08美元,同比增长19%。公司同时上调2026全年指引:总营收由此前预期的382亿至394亿美元上调至389亿至397亿美元;非GAAP每股收益由22.30至23.50美元上调至22.90至23.70美元。尽管业绩与指引均超预期,安进股价盘后走低。截至发稿,该股盘后下跌1.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680477252","title":"安进第三季度调整后每股收益6.45美元,预估5.77美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2680477252","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680477252?lang=zh_cn&edition=full","pubTime":"2026-11-04 05:01","pubTimestamp":1793739673,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0122379950.USD","IE0009355771.USD","LU1061106388.HKD","LU1236620834.HKD","AMGN","LU1983299246.USD","IBBQ","IBB","IE00BJT1NW94.SGD","LU0320765992.SGD","LU1057294990.SGD","BK4585","BBH","SG9999001440.SGD","BK4534","IE00B2B36J28.USD","BK4581","IE00B4R5TH58.HKD","LU2242652126.USD","UDN","BK4566","LU2089984988.USD","UUP","LU2242646821.SGD","BK4533","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0109394709.USD","BK4599","LU1236620750.USD","BIB","LU0289739699.SGD","LU1023059063.AUD","LU2112291526.USD","BK4139","PBE","BK4588","IE00BFTCPJ56.SGD","LU1571399168.USD","IE0002141913.USD","TBXU","LU2468319806.SGD","PJP","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110876676","title":"异动解读|安进盘中上涨3.07%,肺癌联合疗法进展叠加机构看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1110876676","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110876676?lang=zh_cn&edition=full","pubTime":"2026-10-30 22:05","pubTimestamp":1793369110,"startTime":"0","endTime":"0","summary":"10月30日,安进盘中上涨3.07%,报471.375美元/股,成交额1.83亿美元。消息面上,市场继续消化其与阿斯利康联合疗法在广泛期小细胞肺癌上的积极研究结果,并叠加多家机构近期上调目标价。已披露数据显示,在英飞凡方案中加入Imdelltra后,患者死亡风险降低58%,中位生存期为21.1个月,高于单用英飞凡的12.7个月;一年生存率接近80%,而单药为53%。近期Jefferies将目标价升至428美元,Oppenheimer升至480美元,Goldman Sachs升至481美元,临床催化与机构偏多观点共同支撑股价表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安进盘中上涨,肺癌联合疗法数据亮眼","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134855954","title":"异动解读|安进盘前上涨3.1%,肺癌联合疗法进展叠加机构看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1134855954","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134855954?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:58","pubTimestamp":1793361499,"startTime":"0","endTime":"0","summary":"10月30日,安进盘前上涨3.1%,报474.4美元/股,成交额161.15万美元。消息面上,市场继续消化其与阿斯利康联合疗法在广泛期小细胞肺癌上的积极研究结果,并叠加多家机构近期上调目标价。已披露数据显示,在英飞凡方案中加入Imdelltra后,患者死亡风险降低58%,中位生存期为21.1个月,高于单用英飞凡的12.7个月;一年生存率接近80%,而单药为53%。近期Jefferies将目标价升至428美元,Oppenheimer升至480美元,Goldman Sachs升至481美元,临床催化与机构偏多观点共同支撑股价表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安进盘前上涨,肺癌联合疗法数据亮眼","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133798394","title":"美股夜盘 | 芯片股集体重挫,英特尔暴跌逾22%,ARM跌超7%,闪迪、美光等存储股普跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1133798394","media":"美股夜盘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133798394?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:06","pubTimestamp":1793318765,"startTime":"0","endTime":"0","summary":"道指期货涨0.06%,标普500期货跌0.63%,纳指期货跌1.54%,夜盘情绪偏空。吉利德科学涨2.71%。爱迪生国际跌6.23%,第三季度营收下滑且逊于预期。芯片股下跌,英特尔跌22.62%,三倍做多半导体ETF-Direxion Daily跌13.33%,ARM Holdings跌7.05%,美国超微公司跌6.09%,迈威尔科技跌4.32%,超微电脑跌3.80%,Cerebras Systems跌3.66%,拉姆研究跌3.03%。其中,迈威尔科技受收购Lumentum谈判影响。存储芯片股下跌,Roundhill Memory ETF跌3.77%,闪迪跌3.71%,西部数据跌3.67%,希捷科技跌3.57%,美光科技跌3.49%。","market":"us","thumbnail":"https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTW","LU0154236417.USD","SGXZ99366536.SGD","LU1496350171.SGD","LU2089284900.SGD","AZYY","LRCC","BK4535","BK4592","AMDY","LU0683600562.USD","SMYY","LU2543165471.USD","LU2065169927.USD","LU0310799852.SGD","AMZN","LU0048573561.USD","LU0203202063.USD","LU1823568750.SGD","MEDI","BK4568","LU0321505868.SGD","LU1983299246.USD","SG9999004303.SGD","SPYH","MIC","LU0823411888.USD","IE00B4R5TH58.HKD","LU2065171402.SGD","LU1064131342.USD","LU2637965513.SGD","LU0210533765.USD","LU0823434583.USD","BK4561","LU1023059063.AUD","LU2462591350.SGD","LU1201861249.SGD","MRVX","BK4533","LU1232071149.USD","IE00B19Z3B42.SGD","LU0157215616.USD","LU0289941410.SGD","AMZZ","LU1267930573.SGD","LU2860962120.EUR","VOO","IE00B4YYXB79.USD","LU2242650005.HKD","IE000ITXATA3.USD","LU2505996681.GBP","IBB","CBRZ","LU1057294990.SGD","MRVL","LU0208291251.USD","IE00BQXX3F31.USD","LU2360032135.SGD","LU2111349929.HKD","LU1934455277.USD","BK4604","LU1935042991.SGD","SG9999018865.SGD","LU0109391861.USD","LU2361044865.SGD","LU1989764748.USD","RTH","AIS","LU0096362180.USD","LU2054465674.USD","LU1084165304.USD","IE00B5949003.HKD","SDS","LU0889565916.HKD","IE00BKPKM429.USD","LU1116320737.USD","LU2896262040.SGD","LU0158827948.USD","LU2430703095.HKD","IE00BJLML261.HKD","LU0345774391.USD","BK4585","DMAX","LU1718418525.SGD","LINT","LU2063271972.USD","BK4122","LU0238689110.USD","LU1496350502.SGD","IE00BSNM7G36.USD","LU2236285917.USD","IE00B3SWFQ91.USD","CBRX","LU1935043023.USD","LU2023251221.USD","LU0072462426.USD","DRIV","UDOW","SG9999018857.SGD","LU0070302665.USD","LRCU","LU1935042488.USD","IE0003U64NQ7.SGD","LU2357305700.SGD","LU0719512351.SGD","LU0265550946.USD","LU2097829019.USD","IBBQ","LU0787776722.HKD","LU2108987350.USD","LU2746668461.USD","LU2247934214.USD","LU1839511570.USD","SNDC","IE00BJJMRY28.SGD","LU1917777945.USD","LU0390134368.USD","SPXS","LU0823434740.USD","LU0823421333.USD","LU0345769128.USD","DOG","LU1585245621.USD","BK4507","STXU","STXL","AMGN","LU2462157665.USD","LU0494093205.USD","SPY","LU2125154935.USD","IE000SO60NU8.SGD","LU0320765059.SGD","LU0871640123.AUD","LU2954938101.SGD","SNXX","SMCL","BK4581","LU1720051017.SGD","LU2764263203.CNY","LU0096364046.USD","LU2471134796.USD","LU0029864427.USD","SDOW","BBH","BK4605","LU2087625088.SGD","LU1236620750.USD","SNDK","LU1974910355.USD","BK4141","SG9999014914.USD","IE00B7SZLL34.SGD","LU2211815571.USD","LU0128525929.USD","LU2361045086.USD","BK4579","LU1861127337.USD","LU2089283258.USD","SG9999015978.USD","LU2430703251.USD","LU2237438978.USD","PJP","AMZU","SMCX","LU0345774631.USD","LU2168563687.JPY","HULL","IE0002141913.USD","SPDN","PBE","LU2168564149.EUR","SG9999001440.SGD","HK0000304797.USD","LU2362540622.SGD","DDM","TTEQ","LU1037948897.HKD","SGXZ23171101.USD","SPYU","LU1074936037.SGD","CHPS","BK4515","LU2999663052.SGD","LU1323610961.USD","LU1989764664.SGD","LU1069344957.HKD","HK0000532082.HKD","SMCZ","IE00BKVL7J92.USD","BK4551","SGXZ80539844.SGD","LU2746668974.SGD","STXX","LU0211327993.USD","LU2237957902.USD","WDCC","IE000BZT7R73.USD","LU2087621335.USD","SMCY","LU0122379950.USD","LU1066051225.USD","LU2211817866.USD","LU1935042215.USD","LU2089984988.USD","LU1236620834.HKD","IE000F7OJYX1.SGD","IE00BFSS8Q28.SGD","LU0689472784.USD","BE","LU0302445910.USD","LU0820562030.AUD","IVV","IE000WAW04H5.SGD","LU0211328371.USD","LU2112291526.USD","LU2750360997.AUD","LU0957791311.USD","LU2250418816.HKD","BK4512","LU2264538146.SGD","LU0980610538.SGD","AMZO","HK0000304805.HKD","LU0528227936.USD","LU0348723411.USD","AMDW","LU0234572021.USD","LU1914381329.SGD","BK4599","LU0417517546.SGD","LU0011850046.USD","SMCC","BK4583","IE00BYQQ9H92.USD","BK4578","IE0002270589.USD","IE00B19Z8X17.USD","LU1435385759.SGD","LU0820561818.USD","LU2471134879.HKD","LU0965509283.SGD","LU0353189763.USD","LU1941712348.USD","BEC","SINTCmain","LU2065171311.SGD","LU2213496289.HKD","SMCI","SPXU","IE000MB6IJN5.SGD","LU0267386448.USD","XNTK","LU1868836914.USD","SG9999015986.USD","LU0320765489.SGD","FTXL","LU0889565833.HKD","LU2237957811.SGD","LU0143551892.USD",".IXIC","IE000M9KFDE8.USD","LU2505996509.AUD","LU0053666078.USD","LU2430703178.SGD","LU0314104364.USD","IE00BK4W5M84.HKD","LU0308772762.SGD","LU2764262908.HKD","LU1861559042.SGD","IE0009356076.USD","LU2275660780.HKD","IE00B775H168.HKD","LU0466842654.USD","IE00B7KXQ091.USD","LU2023250843.SGD","LU0072461881.USD","IE00BJTD4N35.SGD","SNDG","LU0456855351.SGD","LU0672654240.SGD","LU1316542783.SGD","IE0004445015.USD","MUD","MUYY","IE00B775SV38.USD","LU2271345857.HKD","EIX","LU0056508442.USD","BK4588","LU0061474705.USD","LU1791710400.SGD","LU1301847155.USD","LU2028103732.USD","IE000KEQY171.SGD","LU0082616367.USD","LU0648001328.SGD","LU1880398471.USD","DXD","AMZG","BK4538","SPXL","IE00BJJMRZ35.SGD","SGXZ44715902.SGD","LU2471134523.USD","LU2244417387.USD","OGIG","LU1145028129.USD","BK4503","LU0965509101.SGD","ARMW","LU0345769631.USD","LU2381873111.SGD","LU1244550221.USD","SGXZ31699556.SGD","LU1261432733.SGD","LU0882574055.USD","LU2420271590.USD","WANT","LU0215105999.USD","LU0061474960.USD","LU0210528500.USD","IE00BK4W5L77.USD","IE00BZ1G4Q59.USD","LU1551013425.SGD","LU0985320562.USD","SPYQ","MVLL","LU0274383776.USD","LU2168564065.EUR","LU1571399168.USD","LU2552382132.HKD","IE00BMPRXN33.USD","LU0109392836.USD","LU1046421795.USD","IE00B19Z9505.USD","LU1674673428.USD","LU0342679015.USD","LU2083900584.USD","SG9999002224.SGD","LU2242646821.SGD","IE00B3S45H60.SGD","LU1674673691.USD",".SPX","IE00B19Z8W00.USD","LU0965509010.AUD","LU0080751232.USD","LU1066051498.USD","LU1037948541.HKD","LU1778281490.HKD","LU0070217475.USD","LU0784384876.USD","BK4532","CLIX","IE00BQXX3D17.EUR","AIQ","SAMZNmain","LU0321505439.SGD","LU2461242641.AUD","IE00BQXX3C00.GBP","HIBL","LU0724617625.USD","LU2552382215.SGD","LU2148611432.USD","IE00B2B36J28.USD","AMUU","LU1429558221.USD","LU1153585028.USD","LU1814569148.SGD","SG9999014898.SGD","LU2129689605.HKD","MMAX","LU1235294995.USD","BK4596","SPUU","LU2487616109.SGD","SNDU","LU0149725797.USD","LU1280957306.USD","LU0642271901.SGD","SG9999017495.SGD","LU0138981039.USD","LU0708994859.HKD","LU1868837136.USD","INT","AMDL","LU0323591593.USD","LU0345770993.USD","LU0133085943.USD","LU0742534661.SGD","BEZ","LU0708995401.HKD","LU0949170426.SGD","LU0114720955.EUR","MRVU","LU1244550577.SGD","BK4550","LU2092627202.USD","IE00BMPRXR70.SGD","SOXX","YSPY","SSO","SOXL","SG9999015952.SGD","LU1430594728.SGD","LU2326559502.SGD","IE0034235303.USD","LU2362541513.USD","IE0005OL40V9.USD","INTC","LU0276348264.USD","LU2931357623.SGD","LU0310800379.SGD","AMZW","LU1366333091.USD","SMAX","LU2592432038.USD","SG9999000418.SGD","LU0784383803.USD","LU2720916845.USD","UPRO","SG9999015945.SGD","SPYM","IE0009G5SDU7.USD","LU1935043536.SGD","IE00B3T34201.USD","AMYY","IE0009355771.USD","LU2023250330.USD","SG9999002232.USD","LU1267930490.SGD","BK4602","LU0175139822.USD","LU0162691827.USD","MU","LU2265009873.SGD","IE00B4JS1V06.HKD","AMZD","LU0077335932.USD","LU1548497426.USD","LU2129689431.USD","IE00BKDWB100.SGD","BK4527","SGXZ81514606.USD","MUG","BEX","LU0345768153.USD","QQQA","LU1066053197.SGD","LU0648000940.SGD","IE000YTNTUN2.SGD","LRCX","LU0345770308.USD","LU1934455863.HKD","LU0058720904.USD","GB00BDT5M118.USD","LU1791710582.SGD","ARMU","LU0289739699.SGD","IE0004445239.USD","LU2023250504.SGD","LU1988902786.USD","LU2106854487.HKD","LU1035775433.USD","LU1551013342.USD","IE00BFSS7M15.SGD","LU2417539215.USD","LU0820561909.HKD","BIB","SG9999014880.SGD","LU1868836757.USD","LU0081259029.USD","LU2471134952.CNY","LU1979441026.SGD","LU0174119429.USD","CBRS","IE00B1XK9C88.USD","LU2403377893.USD","LU2750360641.GBP","LU1127390331.HKD","SH","IE00BJJMRX11.SGD","BK4139","BK4575","BEG","LU2065170008.USD","LU0234570918.USD","LU2361044949.HKD","LU0788109477.HKD","LU0786609619.USD","IE00BWXC8680.SGD","LU0048584097.USD","LU0823421416.USD","LU1815333072.USD","LU0784385840.USD","HK0000914686.HKD","LU0251132253.USD","HK0000914660.USD","SG9999002422.SGD","BK4524","SG9999001077.SGD","LU0061475181.USD","LU0859254822.USD","TBXU","LU1116320901.HKD","LU0251142724.SGD","LU1267930730.SGD","STX","LU0107464264.USD","LU2092937148.SGD","AMZP","IE0000B7K699.USD","BK4559","AMAA","LU1935043452.HKD","LU2242652126.USD","LU0187121727.USD","LU0127658192.USD","LU0251131958.USD","LU0784385170.HKD","LU1629891620.HKD","LU0640476718.USD","LU0097036916.USD","AMDC","IE000W1ABFV2.USD","LU2456880835.USD","LU0130103400.USD","LU1803068979.SGD","SNDQ","LU0868494617.USD","LU2468319806.SGD","LU0256863902.USD","LU1066051811.HKD","BK4612","LU1868836591.USD","BK4566","IE00BN29S564.USD","LU1691799644.USD","LU2324357040.USD","BK4554","LU2602419157.SGD","MUZ","LU0289960550.SGD","IE0004086264.USD","LU1852331112.SGD","AMDG","LU0353189680.USD","IE00BJTD4V19.USD","LU2077746001.SGD","IE0004091025.USD","LU2168564495.EUR","LU1934455194.USD","WDCX","LU1804176565.USD","AMZY","BMED","ARMA","LU2168564222.USD","LU1633808545.USD","DAMD","IE0001KFT4U8.USD","AMD","LU2089985449.USD","IE00B19Z3581.USD","TMED","MULL","LU0158827781.USD","LU2756315318.SGD","LU0170899867.USD","DRAM","LU1861558580.USD","LU0109394709.USD","LU0256863811.USD","LU1061106388.HKD","LU0265550359.USD","ARMG","LU0210536198.USD","LU0823416689.USD","LU1880398554.USD","LU0861579265.USD","LU2756315664.SGD","LU2452424414.USD","BK4548","LU1720051108.HKD","WDC","LU2764263039.SGD","LU0354030511.USD","LU0345768740.USD","LU0943347566.SGD","LU2242649171.HKD","SGXZ51526630.SGD","IE00BFTCPJ56.SGD","INYY","LU0316494557.USD","IE00BFXG0V08.USD","LU0203201768.USD","LU2362541273.HKD","IE00BMPRXQ63.HKD","LU2462591277.SGD","ILDR","AMDD","LU0130102774.USD","LU0965508806.USD","LU2357627491.SGD","CNAV","LU2360106780.USD","IE00B1BXHZ80.USD","LU0312595415.SGD","LU1244550494.USD","ARM",".DJI","IE00BJT1NW94.SGD","LU1366192091.USD","LU0198837287.USD","LU2552382058.USD","LU1868837300.USD","LU0964807845.USD","IE00B5TLWC47.USD","LU0320765992.SGD","LU2463028550.USD","BK4220","BK4534","LEGR","LU0354030438.USD","DIA","LU1883839398.USD","BK4529","BK4598","ONLN","LU2129689514.USD","SG9999014906.USD","GILD","LU1119994496.HKD","LU0882574139.USD","LU2125154778.USD","BK4543","CBRG","LU0079474960.USD","LU2317271919.USD","LU1201861165.SGD","MUU","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139764693","title":"异动解读|安进盘中上涨3.48%,肺癌联合疗法进展叠加机构上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1139764693","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139764693?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:40","pubTimestamp":1793281225,"startTime":"0","endTime":"0","summary":"10月29日,安进盘中上涨3.48%,报466.795美元/股,成交额8272.24万美元。消息面上,市场继续消化其与阿斯利康联合疗法在广泛期小细胞肺癌上的积极研究结果,并叠加多家机构近期上调目标价。已披露数据显示,在英飞凡方案中加入Imdelltra后,患者死亡风险降低58%,中位生存期为21.1个月,高于单用英飞凡的12.7个月;一年生存率接近80%,而单药为53%。近期Jefferies将目标价升至428美元,Oppenheimer升至480美元,Goldman Sachs升至481美元,临床催化与机构偏多观点共同支撑股价表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安进大涨,肺癌联合疗法数据亮眼","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133934515","title":"异动解读|安进盘前上涨3.17%,肺癌联合疗法进展叠加机构上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1133934515","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133934515?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:52","pubTimestamp":1793267541,"startTime":"0","endTime":"0","summary":"10月29日,安进盘前上涨3.17%,报466.15美元/股,成交额47.79万美元。消息面上,市场继续消化其与阿斯利康联合疗法在广泛期小细胞肺癌上的积极研究结果。已披露数据显示,在英飞凡方案中加入Imdelltra后,患者死亡风险降低58%,一年生存率接近80%,高于单用英飞凡的53%。与此同时,多家机构近期上调目标价,Jefferies升至428美元,Oppenheimer升至480美元,Goldman Sachs升至481美元。临床催化与机构偏多观点共同支撑股价表现。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安进盘前上涨,肺癌联合疗法数据亮眼","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141104061","title":"异动解读|安进夜盘上涨3.58%,联合疗法积极数据叠加机构看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1141104061","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141104061?lang=zh_cn&edition=full","pubTime":"2026-10-29 09:24","pubTimestamp":1793237060,"startTime":"0","endTime":"0","summary":"10月29日,安进夜盘上涨3.58%,报467.99美元/股,成交额21.13万美元。同时,多家机构近期上调目标价,Jefferies将目标价升至428美元,Oppenheimer升至480美元;市场还预计公司将于11月3日披露的季度营收约100.71亿美元、同比增长12.31%,调整后每股收益约5.79美元。临床进展与机构偏多观点共同支撑股价表现。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安进夜盘上涨,肺癌新药数据大超预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143367221","title":"财报前瞻 | 安进本季度营收预计增12.31%,机构观点看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1143367221","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143367221?lang=zh_cn&edition=full","pubTime":"2026-10-27 08:03","pubTimestamp":1793059435,"startTime":"0","endTime":"0","summary":"安进将于2026年11月03日发布最新季度财报,市场预期稳步向好、产品管线进展受到关注。一致预期显示,安进本季度营收约为100.71亿美元,同比增12.31%;调整后每股收益约为5.79美元,同比增15.53%;当前未见针对毛利率与净利率的明确预测数据披露,故不展示并以公司正式口径为准。安进上季度营收100.54亿美元,同比增9.53%;毛利率72.64%;归属于母公司股东的净利润23.75亿美元;净利率23.62%;调整后每股收益6.29美元,同比增4.49%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 安进本季度营收预计增12.31%,机构观点看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678168327","title":"美股异动丨安进盘前涨超1% 联合疗法在小细胞肺癌治疗上取得积极研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2678168327","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678168327?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:17","pubTimestamp":1793002675,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BJJMRZ35.SGD","LU0289739699.SGD","LU0320765992.SGD","LU1983299246.USD","IE00B4R5TH58.HKD","LU2242652126.USD","LU2089984988.USD","IE00B2B36J28.USD","BK4599","IE0009355771.USD","LU0122379950.USD","BK4566","BIB","LU1236620750.USD","TBXU","BK4585","IE00BJT1NW94.SGD","SG9999001440.SGD","LU0889565916.HKD","PBE","IBB","LU0868494617.USD","BK4533","LU2112291526.USD","BBH","LU0058720904.USD","LU1236620834.HKD","AMGN","LU2468319806.SGD","BK4581","BK4588","LU0109394709.USD","PJP","LU1057294990.SGD","LU1061106388.HKD","BK4139","LU2242646821.SGD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1571399168.USD","IBBQ","BK4534","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":0.0114},{"period":"1month","weight":0.0928},{"period":"3month","weight":0.1215},{"period":"6month","weight":0.4271},{"period":"1year","weight":0.3859},{"period":"ytd","weight":0.4227}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"安进公司于1980年在加利福尼亚成立,并于1987年成为特拉华州的一家公司。该公司发现、开发、制造和交付创新药物,以对抗世界上一些最棘手的疾病。该公司专注于高度未满足的医疗需求领域,并利用其专业知识努力寻求能够显著改善人们生活的解决方案,同时还能减轻疾病带来的社会和经济负担。该公司在40多年前帮助启动了生物技术产业,并已成长为世界领先的独立生物技术公司之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.651163,"avgChangeRate":0.034336},{"month":2,"riseRate":0.488372,"avgChangeRate":0.00202},{"month":3,"riseRate":0.511628,"avgChangeRate":0.016602},{"month":4,"riseRate":0.44186,"avgChangeRate":-0.003156},{"month":5,"riseRate":0.511628,"avgChangeRate":0.022981},{"month":6,"riseRate":0.511628,"avgChangeRate":0.005534},{"month":7,"riseRate":0.772727,"avgChangeRate":0.052813},{"month":8,"riseRate":0.613636,"avgChangeRate":0.006989},{"month":9,"riseRate":0.5,"avgChangeRate":0.001801},{"month":10,"riseRate":0.545455,"avgChangeRate":0.023448},{"month":11,"riseRate":0.613636,"avgChangeRate":0.021824},{"month":12,"riseRate":0.627907,"avgChangeRate":0.045446}],"exchange":"NASDAQ","name":"安进","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安进,AMGN,安进股票,安进股票老虎,安进股票老虎国际,安进行情,安进股票行情,安进股价,安进股市,安进股票价格,安进股票交易,安进股票购买,安进股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}